8-K/A - NSPR - Equibles

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K/A

(Amendment No. 1)

CURRENT

REPORT

Pursuant

to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Dateof Report (Date of earliest event reported): September7, 2025 (July 30, 2025)

InspireMD,Inc.

(Exactname of registrant as specified in its charter)

Delaware	001-35731	26-2123838
(State or other jurisdiction<br><br> <br>of incorporation)	(Commission<br><br> <br>File Number)	(IRS Employer<br><br> <br>Identification No.)
6303 Waterford District Drive, Suite 215<br><br> <br>Miami, Florida	33126
---	---
(Address of principal executive offices)	(Zip Code)

Registrant’stelephone number, including area code: (888) 776-6804

(Formername or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common<br> Stock, $0.0001 par value per share	NSPR	The<br> Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item5.02 Election of Directors

On July 31, 2025, InspireMD, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) with the Securities and Exchange Commission (“SEC”) announcing that its board of directors (the “Board”) appointed Mr. Raymond W. Cohen to serve as a Class 3 director on the Board, with a term expiring at the Company’s 2026 annual meeting of stockholders. At the time the Original Form 8-K was filed, the Board had not made a determination regarding any Board committee assignments for Mr. Cohen.

On September 7, 2025, the Board appointed Mr. Cohen to serve as a member of the Audit Committee and the Compensation Committee of the Board.

This Amendment No. 1 to the Original Form 8-K is being filed solely to report the Board committees to which Mr. Cohen has been appointed, as required by the SEC. Except as set forth herein, the Original Form 8-K remains unchanged in all respects.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

****		INSPIREMD, INC.
Date:	September<br> 8, 2025	By:	/s/ Marvin Slosman
		Name:	Marvin<br> Slosman
		Title:	Chief<br> Executive Officer